In Parting Shot At Pharma, Trump CMS Weakens Part D Patient Protections

By John Wilkerson / January 19, 2021 at 8:14 PM

CMS is using a demonstration to weaken two pillars of patient protections in Part D: protected drug classes and the requirement that insurers cover at least two drugs in each class.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.